Validation of 2-year (123)I-meta-iodobenzylguanidine-based cardiac mortality risk model in chronic heart failure

AIMS: The aim of this study was to validate a four-parameter risk model including (123)I-meta-iodobenzylguanidine (MIBG) imaging, which was previously developed for predicting cardiac mortality, in a new cohort of patients with chronic heart failure (CHF). METHODS AND RESULTS: Clinical and outcome d...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakajima, Kenichi, Nakata, Tomoaki, Doi, Takahiro, Kadokami, Toshiaki, Matsuo, Shinro, Konno, Tetsuo, Yamada, Takahisa, Jacobson, Arnold F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6012774/
https://www.ncbi.nlm.nih.gov/pubmed/29415138
http://dx.doi.org/10.1093/ehjci/jey016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6012774/
https://www.ncbi.nlm.nih.gov/pubmed/29415138
http://dx.doi.org/10.1093/ehjci/jey016

Ejemplares similares